Altered soluble epoxide hydrolase-derived oxylipins in patients with seasonal major depression: An exploratory study
- 1 June 2017
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 252, 94-101
Abstract
No abstract availableKeywords
Funding Information
- NIEHS (R01 ES002710)
- Superfund Research Program (P42 ES04699)
- NIH (U24 DK097154)
This publication has 55 references indexed in Scilit:
- The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-AnalysisNeuropsychopharmacology, 2011
- Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipidsJournal of Lipid Research, 2010
- Arachidonic Acid-metabolizing Cytochrome P450 Enzymes Are Targets of ω-3 Fatty Acids*Journal of Biological Chemistry, 2010
- Preparation of fatty acid methyl esters for gas-liquid chromatographyJournal of Lipid Research, 2010
- A Meta-Analysis of Cytokines in Major DepressionBiological Psychiatry, 2010
- Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseasesNature Reviews Drug Discovery, 2009
- Quantitative Profiling Method for Oxylipin Metabolome by Liquid Chromatography Electrospray Ionization Tandem Mass SpectrometryAnalytical Chemistry, 2009
- Lipoprotein lipase releases esterified oxylipins from very low-density lipoproteinsProstaglandins, Leukotrienes and Essential Fatty Acids, 2008
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory painLife Sciences, 2006